|
| Characteristic | Total () |
|
| Age at the index hospitalization, in years, median (IQR) | 4.5 (1.4-14.1) |
| Male, in (%) | 99 (49.8%) |
| Hospital length of stay during the index hospitalization, in days, median (IQR) | 3.0 (2.0-7.0) |
| Follow-up since the index hospitalization, in days, median (IQR) | 249.0 (152.0-438.5) |
| Endpoint, in (%) | |
| Active insurance/study deadline | 184 (92.5%) |
| Loss of insurance | 12 (6.0%) |
| Death | 3 (1.5%) |
| Hemodialysis, in (%) | |
| Previous hemodialysis | 0 (0.0%) |
| Hemodialysis during or after the index hospitalization | 2 (1.0%) |
| Number of morbidities, in (%) | |
| 0 | 73 (36.7%) |
| 1 | 63 (31.7%) |
| ≥2 | 63 (31.7%) |
| Morbidities, in (%) | 126 (63.3%) |
| Asthma | 72 (36.2%) |
| Neurologic diseases | 41 (20.6%) |
| Gastrointestinal diseases | 24 (12.1%) |
| Congenital or chromosomal abnormalities | 22 (11.1%) |
| Heart failure | 19 (9.5%) |
| Obesity | 15 (7.5%) |
| Chronic lung disease (except for asthma) | 10 (5.0%) |
| Diabetes | 7 (3.5%) |
| Readmissions () | |
| Admissions during the follow-up period, in | 271 |
| Readmissions during the follow-up period, in (%) | 72 (26.6%) |
| Number of people who were readmitted during the follow-up period, in (%) | 43 (21.9%) |
| Readmissions within 30 days after the discharge of the index hospitalization, in (%) | 27 (10.0%) |
| Number of people readmitted within 30 days after the discharge of the index hospitalization, in (%) | 16 (8.2%) |
| Time elapsed between the discharge of the index hospitalization and the first readmission within 30 days, in days, median (IQR) | 10.5 (5.3-14.3) |
| Readmissions related to COVID-19 after the index hospitalization, in (%) | 28 (10.3%) |
| Number of people readmitted related to COVID-19 after the index hospitalization, in (%) | 22 (11.2%) |
| Time elapsed between the discharge of the index hospitalization and the first readmission related to COVID-19, in days, median (IQR) | 47.5 (15.0-64.5) |
|
